Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 209 participants.
Also called NCT03720639
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 209 participants
- Sponsor
- Registry
-
NCT03720639
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03720639. Randomized; no masking; primary purpose diagnostic. Start 2018-05-18 (actual); primary completion 2020-03-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study
- Condition
- Cardiac Arrythmias
- Condition
- Syncope
- Condition
- Atrial Fibrillation
- Condition
- Atrial Flutter
- Condition
- Tachycardia
- Condition
- Stroke
- Intervention (Device)
- Abbott, Inc Confirm Rx™ versus Medtronic, Inc Reveal LINQTM
- Lead sponsor
- Sparrow Clinical Research Institute
- Collaborator
- Abbott
Record details
- Record id
cardio:ct-nct03720639- Content hash
09b606e1e22baddadc197144d8a2b6a79cafdd995f12857816e2175366f69917